Encapsulate
Farmington
About Encapsulate
Encapsulate is a biotechnology company that develops automated tumor systems that screen the response profile of cancer patients to chemotherapy drugs and determines effective personalized treatment regimens. The company's technology uses cancer cells during initial cancer diagnosis and is grown and preserved them as microtumors that are used to evaluate the efficacy of chemotherapeutic or biotherapeutic drugs on an individualized basis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.7M
- Funding stage: Seed
- Last round: Grant (Aug 2025)
- Website: encapsulate.bio
- Phone: +1 2672907779
Industries & Categories
Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/encapsulate-103994 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.